Journal article
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG – RAPID Trial): A structured summary of a study protocol for a randomised controlled trial
- Abstract:
-
In December 2019, the first reports of COVID-19, a disease caused by a new severe acute respiratory syndrome of coronaviral etiology (SARS-CoV-2), were received from Wuhan (Hubei Province, China). Since then, the disease has become a global pandemic. To date, more than 2.8 million people have died (WHO, 2021). SARS-CoV-2 virus became the seventh known variant of coronavirus pathogenic to humans. The aim – to assess the impact of SARS-CoV-2 infection on the prevalence of stroke in the countrie...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 443.1KB, Terms of use)
-
- Publisher copy:
- 10.1186/s13063-021-05076-0
Authors
- Publisher:
- BioMed Central
- Journal:
- Trials More from this journal
- Volume:
- 22
- Issue:
- 1
- Pages:
- 202-202
- Article number:
- 202
- Publication date:
- 2021-03-10
- DOI:
- EISSN:
-
1745-6215
- ISSN:
-
1745-6215
- Language:
-
Ukrainian
- Keywords:
- Pubs id:
-
1280725
- Local pid:
-
pubs:1280725
- Source identifiers:
-
W3134959801
- Deposit date:
-
2026-04-28
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2021
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record